Series A Funding Awarded to Nob Hill Therapeutics to Advance Breakthrough Respiratory Technologies
Nob Hill Therapeutics, Inc. (NHT), an early-stage company developing innovative treatments for lung diseases, has secured $3 million in Series A funding led by Tramway Venture Partners, with participation from […]